Phase I study of safety and efficacy of allogeneic natural killer cell therapy in relapsed/refractory neuroblastomas post autologous hematopoietic stem cell transplantation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Phase I study of safety and efficacy of allogeneic natural killer cell therapy in relapsed/refractory neuroblastomas post autologous hematopoietic stem cell transplantation

Published:2024-09-09 Issue:1 Volume:14 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Mohseni Rashin,Mahdavi Sharif Pouya,Behfar Maryam,Shojaei Sahar,Shoae-Hassani Alireza,Jafari Leila,Khosravi Abbas,Nikfetrat Zeynab,Hamidieh Amir Ali

Funder

Tehran University of Medical Sciences and Health Services

Publisher

Springer Science and Business Media LLC

Link

https://www.nature.com/articles/s41598-024-70958-7.pdf

Reference74 articles.

1. Knaul, F. M. et al. Avoidable mortality: The core of the global cancer divide. J. Glob. Oncol. 4, 1–12 (2018).

2. Qiu, B. & Matthay, K. K. Advancing therapy for neuroblastoma. Nat. Rev. Clin. Oncol. 19(8), 515–533 (2022).

3. Maris, J. M. Recent advances in neuroblastoma. N. Engl. J. Med. 362(23), 2202–2211 (2010).

4. Irwin, M. S. et al. Revised neuroblastoma risk classification system: A report from the children’s oncology group. J. Clin. Oncol. 39(29), 3229–3241 (2021).

5. Pinto, N. et al. Impact of genomic and clinical factors on outcome of children ≥18 months of age with stage 3 neuroblastoma with unfavorable histology and without MYCN amplification: A children’s oncology group (COG) report. Clin. Cancer Res. 29(8), 1546–1556 (2023).

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP